131 related articles for article (PubMed ID: 32919941)
1. A chemiluminescence immunoassay for the detection of NT-proBNP.
Chen YY; Li SL; Lin HL; Li WD; Zhu XZ; Zhang HL
Anal Biochem; 2020 Dec; 611():113950. PubMed ID: 32919941
[TBL] [Abstract][Full Text] [Related]
2. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
3. Multicenter analytical performance evaluation of the Elecsys proBNP assay.
Sokoll LJ; Baum H; Collinson PO; Gurr E; Haass M; Luthe H; Morton JJ; Nowatzke W; Zingler C
Clin Chem Lab Med; 2004; 42(8):965-72. PubMed ID: 15387451
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)].
Benoit MO; Dautezac F; Taccoen M; Paul JL
Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.
Chien TI; Chen HH; Kao JT
Clin Chim Acta; 2006 Jul; 369(1):95-9. PubMed ID: 16515777
[TBL] [Abstract][Full Text] [Related]
6. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers.
Collinson PO; Barnes SC; Gaze DC; Galasko G; Lahiri A; Senior R
Eur J Heart Fail; 2004 Mar; 6(3):365-8. PubMed ID: 14987590
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a New NT-proBNP Immunoassay on an Automated Core Laboratory System.
Logan S; Di Meo A; Shapero S; Fabros A; Taher J; Kulasingam V
J Appl Lab Med; 2024 May; 9(3):579-585. PubMed ID: 38170842
[TBL] [Abstract][Full Text] [Related]
8. Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010.
Di Serio F; Ruggieri V; Varraso L; De Sario R; Mastrorilli A; Pansini N
Clin Chem Lab Med; 2005; 43(11):1263-73. PubMed ID: 16232094
[TBL] [Abstract][Full Text] [Related]
9. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Analytical Performances and Comparison of 3 NT-proBNP Assays for Diagnosing Heart Failure.
Cho J; Lee JH; Lee SG
Arch Pathol Lab Med; 2023 Aug; 147(8):949-956. PubMed ID: 36308710
[TBL] [Abstract][Full Text] [Related]
11. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
[TBL] [Abstract][Full Text] [Related]
12. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.
Prontera C; Zucchelli GC; Vittorini S; Storti S; Emdin M; Clerico A
Clin Chim Acta; 2009 Feb; 400(1-2):70-3. PubMed ID: 18992732
[TBL] [Abstract][Full Text] [Related]
13. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
14. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.
Porcel JM; Chorda J; Cao G; Esquerda A; Ruiz-González A; Vives M
Respirology; 2007 Sep; 12(5):654-9. PubMed ID: 17875051
[TBL] [Abstract][Full Text] [Related]
15. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
[TBL] [Abstract][Full Text] [Related]
16. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
[TBL] [Abstract][Full Text] [Related]
17. Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea.
Sanz MP; Borque L; Rus A; Vicente B; Ramírez Y; Lasa L
J Clin Lab Anal; 2006; 20(6):227-32. PubMed ID: 17115420
[TBL] [Abstract][Full Text] [Related]
18. Measurement of NT-proBNP with LOCI technology in heart failure patients.
Gruson D; Ahn SA; Lepoutre T; Rousseau MF
Clin Biochem; 2012 Jan; 45(1-2):171-4. PubMed ID: 21843519
[TBL] [Abstract][Full Text] [Related]
19. [Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI].
Alibay Y; Schmitt C; Beauchet A; Dubourg O; Alexandre JA; Boileau C; Jondeau G; Puy H
Ann Biol Clin (Paris); 2005; 63(1):43-9. PubMed ID: 15689311
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic Digital Immunoassay for Point-of-Care Detection of NT-proBNP from Whole Blood.
Chen C; Porter R; Zhou X; Snozek CL; Yang EH; Wang S
Anal Chem; 2024 Jul; 96(26):10569-10576. PubMed ID: 38877973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
